Browsing Centre for Translational Medicine & Therapeutics by Author "Cutrin, JC"
Now showing items 1-3 of 3
-
Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes.
PURVIS, G; Collino, M; Loiola, R-A; Baragetti, A; Chiazza, F; Brovelli, M; Sheikh, MH; Collotta, D; Cento, A; Mastrocola, R -
Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes.
SOLITO, E; PURVIS, GSD; Collino, M; Azevedo Loiola, R; Baragetti, A; Chiazza, F; Brovelli, M; Collotta, D; Sheikh, M; Cento, A (Frontiers Media, 2019-03-27)Annexin A1 (ANXA1) is an endogenously produced anti-inflammatory protein, which plays an important role in the pathophysiology of diseases associated with chronic inflammation. We demonstrate that patients with type-2 ... -
A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice
Collino, M; Benetti, E; Rogazzo, M; Chiazza, F; Mastrocola, R; Nigro, D; Cutrin, JC; Aragno, M; Fantozzi, R; Minetto, MA (2014-12)